share_log

HC Wainwright & Co. Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $5

HC Wainwright & Co. Maintains Buy on AcelRx Pharmaceuticals, Lowers Price Target to $5

HC Wainwright & Co.维持对AcelRx Pharmicals的买入,将目标价下调至5美元
Benzinga ·  2023/09/25 06:19

HC Wainwright & Co. analyst Ed Arce maintains AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and lowers the price target from $8 to $5.

HC Wainwright&Co.分析师埃德·阿尔斯维持AcelRx制药(纳斯达克代码:ACRX)的买入,并将目标价从8美元下调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发